Restaging the Biochemical Recurrence of Prostate Cancer with [<sup>68</sup>Ga]Ga-PSMA-11 PET/CT: Diagnostic Performance and Impact on Patient Disease Management

Restaging the Biochemical Recurrence of Prostate Cancer with [<sup>68</sup>Ga]Ga-PSMA-11 PET/CT: Diagnostic Performance and Impact on Patient Disease Management

Background: Detection rates of [<sup>68</sup>Ga]Ga-PSMA-11 PET/CT on the restaging of prostate cancer (PCa) patients presenting with biochemical recurrence (BCR) have been well documented, but its performance and impact on patient management have not been evaluated as extensively. Method...

Full description

Bibliographic Details
Main Authors: Aloÿse Fourquet, Lucien Lahmi, Timofei Rusu, Yazid Belkacemi, Gilles Créhange, Alexandre de la Taille, Georges Fournier, Olivier Cussenot, Mathieu Gauthé
Format: Article
Language:English
Published: MDPI AG 2021-03-01
Series:Cancers
Subjects:
prostatic neoplasms
positron-emission tomography
decision making
Online Access:https://www.mdpi.com/2072-6694/13/7/1594

Internet

https://www.mdpi.com/2072-6694/13/7/1594

Similar Items